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Abstract
Proline metabolism has an underlying role in apoptotic signaling that impacts tumorigenesis.
Proline is oxidized to glutamate in the mitochondria with the rate limiting step catalyzed by
proline dehydrogenase (PRODH). PRODH expression is inducible by p53 leading to increased
proline oxidation, reactive oxygen species (ROS) formation, and induction of apoptosis.
Paradoxical to its role in apoptosis, proline also protects cells against oxidative stress. Here we
explore the mechanism of proline protection against hydrogen peroxide stress in melanoma
WM35 cells. Treatment of WM35 cells with proline significantly increased cell viability,
diminished oxidative damage of cellular lipids and proteins, and retained ATP and NADPH levels
after exposure to hydrogen peroxide. Inhibition or siRNA-mediated knockdown of PRODH
abolished proline protection against oxidative stress whereas knockdown of Δ1-pyrroline-5-
carboxylate reductase, a key enzyme in proline biosynthesis, had no impact on proline protection.
Potential linkages between proline metabolism and signaling pathways were explored. The
combined inhibition of the mammalian target of rapamycin complex 1 (mTORC1) and mTORC2
eliminated proline protection. A significant increase in Akt activation was observed in proline
treated cells after hydrogen peroxide stress along with a corresponding increase in the
phosphorylation of the fork head transcription factor class O3a (FoxO3a). The role of PRODH in
proline mediated protection was validated in the prostate carcinoma cell line, PC3. Knockdown of
PRODH in PC3 cells attenuated phosphorylated levels of Akt and FoxO3a and decreased cell
survival during hydrogen peroxide stress. The results provide evidence that PRODH is essential in
proline protection against hydrogen peroxide mediated cell death and that proline/PRODH helps
activate Akt in cancer cells.
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Introduction
Proline is a multi-functional imino acid with important roles in primary carbon and nitrogen
metabolism, osmotic and oxidative stress protection, protein chaperoning, cell signaling,
programmed cell death, and nutrient adaptation and survival [1–4]. Proline metabolism
impacts cell survival and death outcomes by influencing the intracellular redox environment
during oxidative and nutritional stress conditions [2, 5, 6]. The oxidation of proline to
glutamate involves two enzymatic steps, which in eukaryotes occurs in the mitochondrion
[7]. In the first step, proline is oxidized to P5C by the flavin-dependent enzyme proline
dehydrogenase (PRODH) also known as proline oxidase (POX) (Fig. 1). The intermediate,
P5C, is hydrolyzed nonenzymatically to γ-glutamate semialdehyde (GSA) which is then
oxidized by P5C dehydrogenase (P5CDH) to glutamate [8]. Glutamate derived from proline
can subsequently enter the TCA cycle via α-ketoglutarate. Conversion of glutamate back to
proline involves three enzymatic steps with the initial two steps catalyzed by the
bifunctional enzyme P5C synthetase (P5CS) to generate P5C [9]. P5C is subsequently
reduced to proline by the NADPH-dependent P5C reductase (PYCR). Metabolic cycling of
proline and P5C via PRODH and PYCR has been shown to increase flux through the
pentose phosphate pathway by helping maintain NADP+ levels in the cytosol [5, 7].
The gene encoding PRODH (PRODH1) is inducible by p53 [10, 11]. PRODH is associated
with the inner mitochondrial membrane with activity likely coupled to reduction of
ubiquinone in the electron transport chain [12, 13]. Upregulation of PRODH by p53 results
in formation of proline-dependent reactive oxygen species (ROS) and induction of intrinsic
and extrinsic apoptotic pathways [11, 14]. Co-expression of manganese superoxide
dismutase blocks apoptosis induced by PRODH, suggesting the involvement of superoxide
[15, 16]. Overexpression of PRODH was also shown to suppress tumorigenesis in
xenografted nude mice [17]. Thus, proline oxidative catabolism has a well-established role
in apoptosis and cancer prevention [11, 17].
Despite its pro-oxidant effects, proline has been shown to protect fungi, plants, and
mammalian cells against oxidative stress [3, 6, 18, 19]. In mammalian cells proline was
observed to decrease apoptosis induced by different oxidative stress agents such as H2O2,
tert-butyl hydroperoxide and the carcinogen, fumonisin [6]. Though numerous studies have
demonstrated the role of proline in stress protection, deciphering the mechanism of proline
protection has been enigmatic. In different organisms proline protection has been postulated
to involve protein chaperoning, direct scavenging of ROS, protection and upregulation of
antioxidant enzymes such as catalase, and maintenance of key redox molecules such as
glutathione and NADPH/NADP+ that are critical for proper redox balance [3, 6, 18, 20, 21].
Here, we seek to provide new insights into the mechanism of proline protection against
oxidative stress by exploring the role of proline metabolic enzymes and signaling pathways
possibly influenced by proline. For this study, we used Wistar melanoma 35 (WM35) cells,
a non-tumorigenic cell line derived from primary, radial growth phase melanoma [22], and
subsequently generalized our findings in the prostate carcinoma line, PC3. WM35 has been
shown to maintain wild type p53 and cell cycle responses similar to melanocytes [22].
Furthermore, a metabolic profiling study showed WM35 cells exhibit significant proline
metabolic flux and TCA cycle activity [23]. We report evidence that PRODH activity is
essential for proline mediated protection of WM35 cells against oxidative stress and identify
signaling pathways that potentially lead to increased cell survival.
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Experimental procedures
Materials
Unless stated otherwise, all chemicals, enzymes and buffers were purchased from Fisher
Scientific and Sigma-Aldrich, Inc. WM35 cells were provided by Dr. Adam Richardson and
Dr. Jeffrey Smith at the Sanford-Burnham Medical Research Institute, La Jolla, CA.
RWPE-1 and PC3 cells were purchased from ATCC.
Antibodies
Antibodies recognizing VDAC/Porin and β-actin were from Sigma. Antibodies against
phospho-Akt (T308), phospho-Akt (S473), total Akt, phospho-FoxO1 (T24), phospho-
FoxO1 (S256), phospho-FoxO3a (T32), and total FoxO1 were from Cell Signaling
Technology. Polyclonal antibodies against PRODH, PYCR1, PYCR2 were custom-made by
Proteintech. Horse radish peroxidase (HRP)-labeled anti-mouse, anti-goat and anti-rabbit
secondary antibodies were from GE Healthcare.
Stress tests and cell viability
WM35 cells were grown in Rosewell Park Memorial Institute-1640 (RPMI-1640) medium
supplemented with 10% fetal bovine serum (FBS) (Phenix) and non-essential amino acids at
37 °C. For WM35 cell culture media, 0.25 μg/ml of antibiotic-antimycotic solution was
used (Invitrogen). PC3 cells were grown in Improved MEM (IMEM) supplemented with
10% FBS and non-essential amino acids. RWPE-1 cells were grown in keratinocyte serum
free medium (K-SFM) supplemented with 10% FBS, bovine pituitary extract and human
recombinant epidermal growth factor (Invitrogen). For stress treatments, WM35,
RWPE-1and PC3 cells were grown to 80% confluence. For the initial time study with
WM35 cells, cells were pretreated with proline (5 mM) for various time points (1–24 h) in
serum containing medium prior to H2O2 stress (0.5 mM, 3 h) in serum free medium. A 12 h
pretreatment period with proline (5 mM) in serum containing medium was then chosen for
all subsequent stress tests with WM35 and RWPE-1 cells. Stress tests were performed by
pretreatment of cells with and without proline (5 mM) in serum containing medium for 12 h.
The media was then changed and cells were incubated for 3 h in serum free medium with
and without H2O2 (50 and 500 μM). During the 3 h H2O2 stress treatment, proline (5 mM)
was supplemented in the serum free medium for the proline treated cells whereas control
cells were not supplemented with proline. After stress treatment, cell viability was
quantified using the tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] (MTS) according to the
recommendation of the manufacturers (Promega). The CellTiter-Glo Luminescent assay
(Promega) was also used as an alternative method according to the recommendation of the
manufacturers. Percent cell survival was determined relative to the appropriate controls.
Stress tests were also performed with WM35 cells using different inhibitor compounds. For
inhibition of PRODH, WM35 cells were incubated with 0–5 mM L-tetrahydro-2-furoic acid
(L-THFA) with and without proline (5 mM) for 12 h prior to 0.5 mM H2O2 stress (3 h). To
inhibit the pentose phosphate pathway, WM35 cells were incubated with
dehydroepiandrosterone (DHEA) (50 μM) and 6-aminonicotinamide (50 μM) for 24 h
before adding proline (5 mM) to the cell culture. After a 12 h incubation with proline,
WM35 cells were then treated with H2O2 as described above. Inhibition of the mTOR
pathway was achieved by incubating WM35 cells with rapamycin (Calbiochem) at 10 nM
and 100 nM concentrations and with KU-0063794 (Selleck) at 10 nM and 20 nM
concentrations for 2 h prior to H2O2 stress. Stock solutions of the inhibitor compounds
DHEA, 6-aminonicotinamide, rapamycin, and KU-0063794 were prepared in dimethyl
sulfoxide (DMSO).
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G6PDH assay
Glucose-6-phosphate dehydrogenase (G6PDH) activity was measured according to the
recommendation of the manufacturer (BioVision). One unit of enzyme is defined as 1 μmol
of product formed per min at 37 °C. Total protein concentration in the cell lysates was
determined using the bicinchoninic acid (BCA) protein assay (Pierce) using bovine serum
albumin as a standard.
Oxidative stress markers
Malondialdehyde was measured using the thiobarbituric acid method [24]. Protein carbonyl
content formed was measured using 2,4-dinitro-phenyl hydrazine and calculated using an
extinction coef3cient of 22 mM−1cm−1 [25]. Total thiol content was measured using dithio-
bis-(2-nitro benzoic acid) and expressed as nanomoles per milligram protein as described
[26].
Proline, ATP, and NADPH measurements
Intracellular proline levels were measured using the acid-ninhydrin method as described
earlier [6, 27]. Briefly, WM35, RWPE-1, and PC3 cells were trypsinized, washed twice with
PBS, pelleted by centrifugation, and resuspended in 0.5 ml of Mammalian protein extraction
reagent (M-PER). Cell lysates were prepared according to the manufacturer’s instruction
with the addition of mammalian protease inhibitor cocktail (Sigma) and were centrifuged at
17,000 × g for 10 min to obtain a cell free supernatant for the assays. Proline concentrations
were estimated using a standard curve of proline (0–10 mM). The reported proline levels are
the concentration of proline in the final toluene extract and are an average value of four
independent experiments. ATP (Promega) and NADPH/NADP+ (Cell Technology) levels
were estimated according to the manufacturer’s recommendation.
Western blot analysis
Cells grown in 10 cm diameter dishes were rinsed once with ice cold PBS and cell lysates
were prepared using M-PER as described above, along with the addition of mammalian
protease inhibitor cocktail (Sigma) and phosphatase inhibitor (Pierce). Lysates containing
50–100 μg of protein were resolved by SDS-PAGE. Proteins were transferred to a PVDF
membrane and visualized by immunoblotting. Band intensities from Western blots were
analyzed using TotalLab Quant software. Phosphorylated Akt levels were reported with
respect to total Akt and phosphorylation of FoxO3a was normalized with respect to β-actin.
Mitochondrial isolation
Cells were released with trypsin and washed twice via centrifugation with ice cold PBS and
then cell pellets were resuspended in Tris buffer (5 mM, pH 7.4) containing 0.25 M sucrose
and 1 mM EDTA. Cells were hand homogenized using a Dounce homogenizer for 1 min on
ice and centrifuged at 17,000 × g for 15 min (4 °C). The supernatant containing the
mitochondrial-free cytosolic fraction was removed and the pellet was resuspended in a
solution containing 8 M urea, 2 M thiourea, 2% CHAPS and used for Western analysis.
Total protein concentrations were quantified using the Bradford method (Bio-Rad).
siRNA transfection
Cells were transfected with On-Target plus smart pool siRNA of PRODH, PYCR1 and
PYCR2 and On-Target plus Non-targeting Pool referred to as control siRNA (Dharmacon
RNA technologies). siRNA transfection was allowed to proceed for 48–96 h before doing
the stress test or whole cell extract collection. Knockdown was confirmed by Western
analysis. Following transfection, stress tests were performed as described above.
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Statistical analysis
Data are expressed as mean ± standard deviation (SD). Statistical analysis was performed
using student’s t-test. A P value of <0.05 was considered to be statistically significant.
Results
Proline protects WM35 cells
Proline was previously shown to protect several mammalian cell types against H2O2-
induced cell death [6]. To first test whether proline would protect WM35 cells against
oxidative stress, we pretreated WM35 cells with proline. Cells were pretreated with proline
for various time points (1–24 h) prior to H2O2 stress treatment (0.5 mM, 3h). We found that
6 h of pretreatment with proline (5 mM) significantly increased survival of WM35 cells in
the presence of H2O2 relative to control cells not given proline (Fig. 2A). Additional
increased cell survival was observed at incubation times > 12 h. We confirmed the
protective effect of proline addition by luminescence quantification of ATP generation, in
which survival increased from 44% to 78% (Fig. 1B). In further support of engaged
oxidative stress protective mechanisms, WM35 cells exposed to H2O2 exhibited
considerably higher levels of malondialdehyde and protein carbonyl content relative to
control cells indicative of oxidative damage (Fig. 2C and D). In contrast, malondialdehye
was not elevated by H2O2 treatment in the presence of proline, and protein carbonyl levels
were significantly lower after H2O2 stress compared to cells without proline. H2O2 stress
decreased total thiol content in the absence of proline but not when proline cells were
pretreated (Supplementary Fig. 1). Thus, consistent with improving cell survival, proline
limits thiol depletion and oxidative modification of lipids and proteins.
Because proline has been postulated to directly scavenge ROS, we tested the possibility of
proline reacting with H2O2 in the cell medium. The reactivity of proline with H2O2 was
compared to that of pyruvate, a well-established scavenger of H2O2 [28]. Proline did not
significantly diminish H2O2 levels whereas in medium supplemented with pyruvate H2O2
was quickly degraded (Supplementary Fig. 2). We also did not find any evidence for direct
scavenging of hydroxyl radicals by proline using previously published hydroxyl-radical
scavenger assays (data not shown) [29, 30]. Thus, it was concluded that proline protection
against oxidative stress does not involve direct scavenging.
In addition, protection by proline was not mediated through the action of the antioxidant
enzymes catalase, glutathione peroxidase, glutathione S-transferase and glutathione
reductase (Supplementary Fig. 3), since these activities were not altered in the presence of
proline.
Inhibition and siRNA mediated knockdown of PRODH
We next examined the effect of reducing endogenous PRODH activity and expression.
WM35 cells were treated with different concentrations of L-THFA, an inhibitor of human
PRODH [31], during proline supplementation. L-THFA decreased proline protection against
H2O2-induced cell death in a dose-dependent manner (Fig. 3A). At 5 mM L-THFA, proline
did not protect. L-THFA alone had no effect on cell survival. To test whether L-THFA
addition to the culture medium affects proline uptake, we measured intracellular proline
levels in cells treated with L-THFA and proline. Proline treatment increased intracellular
proline by 3-fold relative to controls (Fig. 3B). Addition of L-THFA or H2O2 to the proline
treated cells did not alter intracellular proline levels, suggesting proline transport is not
affected by THFA nor significantly diminished after H2O2 stress (Fig. 3B). The impact of
inhibiting PRODH activity was then tested using PRODH siRNA (siRPODH) transfection
of WM35 cells. Western blot analysis of isolated mitochondria from WM35 cells showed a
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significant loss of PRODH expression after 48 h of siPRODH treatment relative to cells
treated with control siRNA (Fig. 3C). Proline protection against H2O2-induced cell death
was eliminated in cells transfected with siPRODH compared to cells transfected with control
scrambled siRNA (Fig. 3D). These results suggest proline protection is dependent on
PRODH.
siRNA mediated knockdown of PYCR
Recently, fibroblasts isolated from patients with a mutation in the PYCR1 gene were
reported to have altered mitochondrial morphology, mitochondrial membrane potential and
an increased apoptotic rate upon oxidative stress [32]. To test the impact of interrupting the
proline-P5C cycle through PYCR, we performed siRNA knockdown of PYCR1 and
PYCR2. Proline protection against oxidative stress-induced cell death was unaffected even
with virtually complete knockdown of both PYCR isozymes (Fig. 4A-D). Thus, unlike
PRODH, diminished PYCR1 and PYCR2 expression does not appear to impact proline
protection against H2O2 stress, indicating that the proline-P5C cycle may not be critical for
proline protection. Consistent with this result, high flux through the pentose phosphate
pathway was also not required for proline protection (Supplementary Fig. 4).
Cellular ATP and NAPH/NADP+
PRODH may help maintain cellular energy during stress by coupling the oxidation of
proline to the mitochondrial electron transport chain [5]. To test this, we measured the effect
of proline on intracellular ATP and NADPH/NADP+ after 3 h H2O2 stress treatment. ATP
levels and the NADPH/NADP+ ratio were significantly decreased after 3 h of 0.5 mM H2O2
treatment relative to control cells. In cells treated with proline, ATP levels and the NADPH/
NADP+ ratio were near that of control cells (Fig. 5). Thus, proline helps maintain ATP
levels and NADPH/NADP+ in H2O2 stressed cells.
Inhibition of mammalian target of rapamycin complex (mTORC)
Since amino acids have been shown to activate the mammalian target of rapamycin complex
1 (mTORC1) [33, 34], we tested whether mTORC1 is a component of proline protection
against H2O2. Incubation of WM35 cells with 10 nM rapamycin did not alter proline
protection against H2O2 stress suggesting that mTORC1 is not involved in proline protection
(Fig. 6A). However, treatment of cells with a higher concentration of rapamycin (100 nM)
did prevent proline protection (Fig. 6A). Because the rictor-complex of mTOR (mTORC2)
has been reported to be sensitive to rapamycin at high concentrations [35], we tested the
effect of KU-0063794, a compound which inhibits both mTORC1 and mTORC2 [36].
Treatment of WM35 cells with KU-0063794 abolished proline protection against oxidative
stress (Fig. 6B), indicating a role for mTORC2 in proline protection.
Activation of Akt and FoxO3a during H2O2 stress
Akt/PKB (Protein kinase B) is a downstream target of mTORC2 activated in response to
oxidative stress, and a well-known promoter of tumor cell survival, proliferation and
metastasis [37]. The activation of Akt was examined by immunoblot analysis of
phosphorylation sites Thr308 and Ser473 after exposure of cells to H2O2 with or without
proline treatment. At 0.5 h of H2O2 stress, 12-fold and 13-fold increases were observed for
phospho-Akt at Thr308 and Ser473, respectively, relative to control cells (Fig. 7A–C).
Phospho-Akt levels were found to be even higher in proline treated cells exposed to H2O2
stress with 30-fold and 44-fold increases observed for Thr308 and Ser473 sites, respectively,
relative to control cells (Fig. 7A–C). Initial activation of Akt occurs via phosphorylation at
Thr308 by phosphatidylinositol-3,4,5-triphosphate dependent kinase (PI3K) and full
activation of Akt is catalyzed by mTORC2 at S473 [36]. After 3 h, the levels of phospho-
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Akt at Thr308 remained significantly upregulated in cells exposed to H2O2 stress (Fig. 7E
and F) whereas phospho-Akt (Ser473) was no longer upregulated. Proline treatment did not
effect phospho-Akt levels at Thr308 (Fig. 7E) or Ser473 at 3h H2O2 stress.
Complete activation of Akt is known to phosphorylate several downstream targets including
the fork head family of transcription factor class O (FoxO) [38]. We examined the
phosphorylation status of FoxO in H2O2 stressed cells with or without proline treatment. No
significant differences in the phosphorylation of FoxO1 (Ser256) and FoxO4 (Ser193) were
observed after 0.5 and 3 h of H2O2 stress in cells with and without proline (Fig. 7A and E).
In contrast, in cells exposed to H2O2 without proline, phospho-FoxO3a (Thr32) was 6-fold
higher, and ≈16-fold higher when proline was also provided (Fig. 7A and D). Thus,
phospho-FoxO3a was significantly upregulated in proline treated cells, consistent with
significantly higher levels of phospho-Akt (Ser473) observed at 0.5 h of H2O2 stress in cells
with proline (Fig. 7C). At 3h, phospho-FoxO3a (Thr32) had returned to the basal level in all
conditions. Since upregulation of phospho-FoxO3a (Thr32) follows the transient profile
observed for phospho-Akt (Ser473), increased cell survival in the presence of proline may
involve inactivation of FoxO3a via Akt phosphorylation.
Proline protection at lower H2O2 concentration
Proline protection of WM35 cells was also tested using a lower concentration of H2O2 (50
μM) to more closely mimic pathophysiological conditions. Cell survival after H2O2
exposure (50 μM, 3h) increased from 68% to 88% in cells treated with proline (Fig 8A).
Furthermore, phospho-Akt (Thr 308 and Ser 473) and phospho-FoxO3a (Thr 32) were found
to be significantly higher in proline treated cells after 50 μM H2O2 exposure (0.5 h) relative
to H2O2 alone treated cells (Fig. 8B–E). These results are similar to that observed with
higher concentrations of H2O2 (500 μM, 3h) consistent with proilne protecting against
pathophysiological levels of H2O2.
PRODH and Akt in prostate cancer cells
To validate and generalize the roles of PRODH and Akt in proline protection during
oxidative stress injury, we repeated the experiments in a prostate cancer cell line. Proline
biosynthesis is upregulated in clinical samples of prostate cancer suggesting that proline
metabolism may have a role in prostate cancer development [39, 40]. We first measured
intracellular proline levels in normal non-tumorigenic human prostate epithelial cells
(RWPE-1) and in PC3, an androgen independent cancer cell line with constitutively active
Akt [41]. The intracellular proline content was 3-fold higher in PC3 cells (28 ± 1 μg/mg
protein) relative to RWPE-1 cells (9.5 ± 1 μg/mg protein), consistent with the elevated
expression of proline biosynthesis genes previously reported [42]. Addition of proline to
RWPE-1 cells increased survival in the presence of H2O2 (1 mM, 3 h) by about 26% relative
to control cells without proline (Fig. 9A). Because the intracellular proline content of PC3
cells is already similar to that found in cells treated with proline, cells were not incubated
with proline prior to H2O2 stress. Instead, the impact of PRODH in stress protection was
tested by siRNA knockdown of PRODH in cells grown in medium without proline
supplementation. PC3 cells were highly resistant to oxidative stress, with 50% cell survival
still observed at 8 mM H2O2 in cells treated with control siRNA (Fig. 9B). At all H2O2
concentrations tested, survival of PC3 cells treated with siPRODH was decreased by 20–
30% relative to scrambled siRNA treated cells, with 25% cell survival observed at 8 mM
H2O2 (Fig. 9B). Knockdown of PRODH was confirmed by Western analysis (Fig. 9C).
Levels of phospho-Akt (Thr308 and Ser473) were ≈80% lower in cells treated with
siPRODH relative to control cells (Fig. 9D and E). Similarly, phospho-FoxO3a (Thr32) was
also reduced by ≈80% in these cells. These results support a general mechanism implicating
PRODH oxidative metabolism of proline, either from exogenous sources or endogenous
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stores, in the downstream Akt signaling pathways that influence cell survival during
oxidative stress.
Discussion
The mechanism by which proline protects cells against oxidative stress induced apoptosis
and cell death has been relatively unexplored. Here, we show that PRODH activity is
essential for proline protection as knockdown of PRODH activity abrogates proline
protection in WM35 cells and significantly decreases survival of PC3 cells during oxidative
stress. Potential linkages between proline metabolism and other pathways that could be
beneficial for cell survival during oxidative stress were also examined. The proline-P5C
cycle has been implicated as an important mechanism for transferring reducing equivalents
of NADPH from the cytosol into the mitochondria and, helping maintain NADP+ for the
pentose phosphate pathway [5, 43, 44]. In this study, however, knockdown of PYCR1/2 and
inhibition of pentose phosphate pathway enzymes did not block proline protection
suggesting the proline-P5C cycle is not essential. However, ATP levels and the NAPDH/
NADP+ ratio were retained in proline treated cells during oxidative stress suggesting proline
helps combat depletion of ATP and NADPH. A previous study also showed that PRODH
helps maintain ATP levels in cells under nutrient deprivation, thus, proline metabolism
appears to influence cellular ATP during oxidative and nutrient stress [5, 7].
A possible role for mTOR in proline protection was tested as amino acids have been shown
to influence mTORC1 and mTORC2 signaling pathways [45]. Proline protection was lost
only under conditions known to inhibit both mTORC1 and mTORC2 complexes, suggesting
mTORC2 may help mediate cell survival. Upregulation of mTORC2 has previously been
shown to augment Akt phosphorylation at Ser473 and inhibit FoxO-dependent transcription
[38, 45]. Consistent with the involvement of mTORC2, the cytoprotective effects of proline
appear to be mediated by the Akt survival pathway. The Akt pathway is inducible by H2O2
stress [46]. Unexpectedly, phospho-Akt levels were observed to be significantly higher in
cells treated with proline. Concomitant with the transient increase in phospho-Akt (Ser473),
significant induction of phosphorylated FoxO3a was observed in proline treated cells during
stress (0.5 h) (Fig. 7D and 8E). Phosphorylated FoxO binds to the 14-3-3 binding protein
resulting in translocation of FoxO from the nucleus to the cytosol. Removal of FoxO from
the nucleus prevents activation of pro-apoptotic gene targets thereby promoting cell survival
[45, 47]. Thus, increased phospho-FoxO3a is anticipated to inhibit FoxO3a induced cell
death leading to increased survival of proline treated cells during oxidative stress.
The effect of proline and PRODH on the Akt pathway was tested further in prostate cells.
Our motivation for examining PC3 cells was from previous studies showing a significant
increase in proline metabolism in prostate cancer (PCa) metastatic samples suggesting a
clinically relevant proline metabolic shift in PCa progression [42]. Proline levels were found
to be significantly increased in metastatic PCa samples and the key enzyme in proline
biosynthesis, PYCR, is highly expressed in metastatic tumors. Furthermore, it is already
established that activation of phospho-Akt by mTORC2 leads to cell survival in prostate
cancer cells [48] and that androgen independent prostate cancer cells such as PC3, exhibit
higher resistance to H2O2 compared to normal prostate epithelial cells [49].
In agreement with previous studies on prostate cancer clinical samples [39], we found that
PC3 cells have considerably higher levels of proline relative to normal prostate cells
(RWPE-1). Knockdown of PRODH led to a significant decrease in resistance to H2O2 stress
in PC3 cells (Fig. 9B). In addition, significantly decreased levels of phospho-Akt and
phospho-FoxO3a were found in PC3 cells with PRODH knockdown. Importantly, the effect
of PRODH knockdown on Akt phosphorylation in PC3 cells was observed under non-stress
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conditions. Thus, PRODH appears to contribute to Akt activation in PC3 cells, the activation
of which is constitutive due to the lack of functional PTEN in PC3 cells [41]. These results
provide support for a generalized model in which Akt acts as a downstream effector of
proline oxidative metabolism in cancer cells.
Figure 10 summarizes a general model for how proline provides a protective effect against
H2O2 stress. Proline catabolism via PRODH is proposed to help maintain cellular energy,
minimize oxidative damage, and increase activation of the Akt survival pathway. The exact
mechanism by which PRODH influences Akt is not apparent but may involve mTORC2.
Other factors, however, may be involved. In addition to mTORC2, Akt (Ser473)
phosphorylation has been suggested to be catalyzed by several other kinases including MAP
kinase-activated protein kinase 2, protein kinase C isoforms, integrin-linked kinase, and 3-
phosphoinositide dependent protein kinase 1 [50–53]. Interestingly, mTORC2 mediated full
activation of Akt has been shown to induce peroxisomes proliferators activated receptor
(PPAR-γ) [54, 55], which has been shown to induce PRODH expression [56].
Finally, while preparing this manuscript a novel study was published reporting that proline
catabolism extends lifespan in worms [57]. Knockdown of PRODH in a C. elegans daf-2
mutant with impaired insulin and IGF1 signaling was shown to significantly decrease
lifespan. Supplementation of wild-type worms with proline was also found to extend
lifespan [57]. Proline catabolism was proposed to generate transient ROS signals that
activate the worm homologues of p38 MAP kinase and Nrf2, leading to increased
expression of antioxidant enzymes and lifespan [57]. So far, we have not found any
evidence of transient proline-dependent ROS that could potentially impact the Akt signaling
pathway (data not shown), and Nrf2 does not appear to be necessary for proline protection
against oxidative stress induced cell death (Supplementary Figure 5). Future studies which
aim to elucidate the mechanisms by which proline catabolism influences the Akt pathway
should reveal new insights into mitochondrial dependent signaling in stress response.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium]
PPAR peroxisomes proliferators activated receptor
PI3K phosphatidylinositol-3,4,5-triphosphate dependent kinase
PRODH proline dehydrogenase
POX proline oxidase
P5C Δ1-pyrroline-5-carboxylate
P5CDH P5C dehydrogenase
PYCR P5C reductase
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THFA tetrahydro-2-furoic acid
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Supplementary data associated with this article can be found in the online version at doi:
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Highlights
• The mechanism of proline protection against hydrogen peroxide stress was
examined
• Inhibition/knockdown of proline dehydrogenase (PRODH) eliminated proline
protection
• Proline retained ATP/NADPH levels and enhanced the Akt survival pathway
• Knockdown of PRODH in a prostate carcinoma cell line decreased cell survival
• A general model for proline protection is proposed in which PRODH is essential
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Fig. 1.
Proline metabolic pathway. Proline is oxidized to glutamate by proline dehydrogenase
(PRODH) and P5C dehydrogenase (P5CDH) in the mitochondrion. PRODH couples proline
oxidation to reduction of CoQ in the electron transport chain. The enzymes P5C synthetase
(P5CS) and P5C reductase (PYCR) convert glutamate into proline.
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Fig. 2.
Proline protects WM35 cells against oxidative stress. (A) WM35 cells were treated with
(black squares) and without (gray diamonds) proline (5 mM) for 1–24 h and then incubated
with 0.5 mM H2O2 for 3 h in serum free medium. Percent cell survival was estimated using
Natarajan et al. Page 17
Free Radic Biol Med. Author manuscript; available in PMC 2013 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
the MTS cell viability assay. (B) WM35 cells were treated with (proline) and without
(control) proline (5 mM) for 12 h and then incubated with and without 0.5 mM H2O2 (3 h)
in serum free medium. Cell survival measurements were determined using the Cell Titer-Glo
Luminescent assay. (C and D) WM35 cells were treated with (proline) and without (control)
proline (5 mM) for 12 h and incubated with and without 0.5 mM H2O2 (3 h) in serum free
medium. Oxidative stress markers (C) malondialdehyde and (D) protein carbonyls were then
measured as described. Each value represents mean ± SD from five different experiments
(*P < 0.05).
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Fig. 3.
Knockdown of PRODH abolishes proline protection. (A) WM35 cells were treated (12 h)
with and without proline (5 mM) in the presence of increasing concentrations of THFA
(0.1–5 mM). Cells were then incubated with and without 0.5 mM H2O2 (3 h) in serum free
medium. Percent cell survival was estimated using the MTS cell viability assay. Each value
represents mean ± SD of separate experiments (n = 5). *P < 0.05 when compared to H2O2
stress without proline, #P < 0.05 when compared to H2O2 stressed cells treated with proline
and 0.1 mM THFA. (B) Intracellular proline levels in control cells, THFA (5 mM) treated
cells, proline (5 mM) treated cells, and THFA + proline treated cells with and without H2O2
stress (0.5 mM, 3 h). Each value represents mean ± SD of separate experiments (n = 5) (*P
< 0.05). (C) Western analysis of PRODH in WM35 cells transfected with control siRNA
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(siCon, 50 nM) and PRODH siRNA (siPRODH, 50 nM) for 48 h. VDAC is shown as a
control. (D) Percent cell survival of control siRNA (siCon) or PRODH siRNA (siPRODH)
treated WM35cells with and without H2O2 stress in the absence (control) and presence of
proline (5 mM). Percent cell survival was estimated using the MTS cell viability assay. Each
value represents mean ± SD of separate experiments (n = 4) (*P < 0.05).
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Fig. 4.
Knockdown of PYCR. (A) Western blot analysis of PYCR1 in WM35 cells transfected with
control siRNA (siCon, 50 nM) and PYCR1 siRNA (siPYCR1, 50 nM) for 48 h. β-actin is
shown as a control. (B) Western analysis of PYCR1 and PYCR2 in cells transfected with
siCon (50 nM), siPYCR2 alone (50 nM), and siPYCR1 (50 nM) and siPYCR2 (50 nM)
combined (siPYCR1/2, 100 nM total). For siPYCR1/2, 100 nM of siCon was used. β-actin
is shown as a control. (C). Percent cell survival of siCon, siPYCR1, and siPYCR2
transfected cells with and without H2O2 stress in the absence (control) and presence
(proline) of proline (5 mM). (D) Percent cell survival of WM35 cells transfected with siCon
and siPYCR1/2 with and without H2O2 stress in the absence (control) and presence of
proline (5 mM). Percent cell survival was estimated using the MTS cell viability assay. Each
value represents mean ± SD of separate experiments (n = 4) (* P < 0.05).
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Fig. 5.
(A) ATP levels and (B) NADPH/NADP+ ratio were measured in control and proline treated
cells with or without 0.5 mM H2O2 stress (3 h). Each value represents mean ± SD of
separate experiments (n = 4) (*P < 0.05).
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Fig. 6.
Inhibition of mTORC1 and mTORC2. (A) Cell survival of WM35 cells incubated with
rapamycin (10 nM and 100 nM) and treated with and without H2O2 stress (3 h) in the
absence (control) and presence of proline (5 mM). (B) Cell survival rate of WM35 cells
incubated with Ku-0063794 and treated with and without H2O2 stress (3 h) in the absence
(control) and presence of proline (5 mM). Cells treated with DMSO were used as controls.
Percent cell survival was estimated using the MTS cell viability assay. Each value represents
mean ± SD of separate experiments (n = 6) (* P<0.05).
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Fig. 7.
Proline upregulates Akt signaling during H2O2 stress. (A) Western analysis of P-Akt (T308
and S473), P-FoxO3a (T32), P-FoxO1 (S256) and P-FoxO4 (S193) in WM35 cells treated
with and without proline (5 mM) for 12 h and incubated with and without 0.5 mM H2O2
(0.5 h) in serum free medium. Controls are FoxO1, β-actin, and Akt. Quantified levels of
(B) P-Akt-T308 and (C) P-Akt-S473 relative to total Akt (P-Akt/Akt). (D) Quantified levels
of P-FoxO3a-T32 relative to β-actin. Each value represents mean ± SD of separate
experiments (n = 4) (*P < 0.05). (E) Same as panel A except cells were incubated with and
without 0.5 mM H2O2 for 3 h. (F) Quantified levels of P-Akt-T308 relative to total Akt (P-
Akt/Akt). Each value represents mean ± SD of separate experiments (n = 4).
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Fig. 8.
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Proline protection and Akt signaling at lower H2O2 levels. (A) WM35 cells were treated
with (proline) and without (control) proline (5 mM) for 12 h and incubated with and without
50 μM H2O2 (3 h) in serum free medium. Percent cell survival was estimated using the
MTS cell viability assay. (B) Western analysis of P-Akt (T308 and S473) and P-FoxO3a
(T32) in WM35 cells treated with and without proline (5 mM) for 12 h and incubated with
and without 50 μM H2O2 (0.5 h) in serum free medium. Controls are β-actin, and Akt.
Quantified levels of (C) P- Akt-T308 and (D) P-Akt-S473 relative to total Akt (P-Akt/Akt).
(E) Quantified levels of P- FoxO3a-T32 relative to β-actin. Each value represents mean ±
SD of separate experiments (n = 4) (*P < 0.05).
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Fig. 9.
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Knockdown of PRODH and Akt signaling pathway in prostate cancer cells. (A) RWPE-1
cells were treated with and without proline (5 mM) for 12 h and then incubated with 0.5 mM
H2O2 for 3 h in serum free medium. Percent cell survival was estimated using the MTS cell
viability assay. (B) Survival rates of PC3 cells transfected (48 h) with control siRNA (siCon)
and PRODH siRNA (siPRODH) and incubated with different concentrations of H2O2 (0–10
mM) for 3 h. (C) Western blot analysis of PRODH in PC3 cells transfected with siCon (50
nM) and siPRODH (50 nM) for 48 h. VDAC is shown as a control. (D) Western blot
analysis of P-Akt (T308 and S473), P-FoxO3a (T32), and β-actin in PC3 cells transfected
with siCon and siPRODH (48 h). (E) Quantification of P-Akt-T308 and P-Akt-S473 relative
to total AKT (P-Akt/Akt) and P- FoxO3a-T32 relative to β-actin. Each value represents
mean ± SD of separate experiments (n = 4) (* P < 0.05).
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Fig. 10.
Model of proline protection against oxidative stress induced cell death. Proline oxidation in
the mitochondrion is coupled to reduction of the electron transport chain (ETC) by PRODH.
PRODH activity helps support oxidative phosphorylation and ATP formation and prevents
decreases in NADPH/NADP+ which sustains cells during oxidative stress. Through an
unknown mechanism, proline/PRODH further activates Akt during H2O2 stress which leads
to inhibition of FoxO3a and blocks cell death. Activation of Akt by proline and PRODH
may involve mTORC2 or other factors not yet identified.
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